Form 8-K - Current report:
SEC Accession No. 0001493152-24-045083
Filing Date
2024-11-13
Accepted
2024-11-13 15:30:11
Documents
15
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38915
2 ex99-1.htm EX-99.1 82561
3 ex99-1_001.jpg GRAPHIC 10258
  Complete submission text file 0001493152-24-045083.txt   321574

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cocp-20241113.xsd EX-101.SCH 3036
5 XBRL LABEL FILE cocp-20241113_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cocp-20241113_pre.xml EX-101.PRE 24179
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3586
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 241453608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)